Figure 4.
Survival outcomes. Kaplan-Meier estimates of PFS and OS in evaluable patients (A-B) and PFS in patients with prior BTKi exposure (C) and patients with TP53 mutated MCL (D).

Survival outcomes. Kaplan-Meier estimates of PFS and OS in evaluable patients (A-B) and PFS in patients with prior BTKi exposure (C) and patients with TP53 mutated MCL (D).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal